IMT-05 PHASE III RANDOMIZED CLINICAL TRIAL OF AFTV FOR NEWLY DIAGNOSED GLIOBLASTOMA

BACKGROUND: The highly fatal glioblastoma has an extremely poor prognosis and development of a new treatment is desired. Local treatment is limited due to its high invasiveness, and immunotherapy utilizing self-immune mechanism is theoretically expected. An autologous formalin-fixed tumor vaccine (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitta, Masayuki, Muragaki, Yoshihiro, Ishikawa, Eiichi, Maruyama, Takashi, Ikuta, Soko, Saito, Taiichi, Tsuzuki, Shunsuke, Fukui, Atsushi, Mastumura, Akira, Kawamata, Takakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213209/
http://dx.doi.org/10.1093/noajnl/vdz039.079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213209/
http://dx.doi.org/10.1093/noajnl/vdz039.079

Ejemplares similares